Brief: Vivos Therapeutics Prices $4.3 Mln Registered Direct Offering Of Common Stock
19/09/2024 12:38
Sept 19 (Reuters) - Vivos Therapeutics Inc VVOS.O :
* VIVOS THERAPEUTICS ANNOUNCES PRICING OF $4.3 MILLION
REGISTERED
DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER
NASDAQ RULES
* VIVOS THERAPEUTICS INC - TO ISSUE 1,363,812 SHARES AT
$3.15 EACH
Source text for Eikon: ID:nGNX8Jfjgd
Further company coverage: VVOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth